Clinical Trials Sponsored by Cancer Research Institute, New York City

Total 609 results

Leap Therapeutics, Inc.
Cancer Research Institute, New York City

Completed

Trial of TRX518 (Anti-GITR mAb) in Stage III or IV Malignant Melanoma or Other Solid Tumors (TRX518-001)

Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies

United States
Ludwig Institute for Cancer Research
Cancer Research Institute, New York City; MedImmune LLC

Completed

A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers

Melanoma | Sarcoma | Breast Cancer | Solid Tumor | Prostate Cancer | Bladder Cancer | Head and Neck Squamous Cell Carcinoma | Cutaneous T-Cell Lymphoma | Renal Cancer | Merkel Cell Carcinoma | Testicular Cancer

United States
Ludwig Institute for Cancer Research
Cancer Research Institute, New York City; MedImmune LLC

Completed

A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab

Renal Cell Carcinoma | Cervical Cancer | Breast Cancer | Colorectal Cancer | Ovarian Cancer

United States
Ludwig Institute for Cancer Research
Celgene; Cancer Research Institute, New York City; MedImmune LLC

Completed

Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian Cancer

Ovarian Cancer

United States, Switzerland
Ludwig Institute for Cancer Research
Cancer Research Institute, New York City; MedImmune LLC; Targovax ASA

Completed

A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies

Colorectal Cancer | Ovarian Cancer | Appendiceal Cancer

United States
Parker Institute for Cancer Immunotherapy
Bristol-Myers Squibb; Cancer Research Institute, New York City

Completed

Nivolumab With or Without Ipilimumab in Advanced Metastatic Cancer

Advanced Metastatic Cancer | Advanced Prostate Cancer

United States
Canadian Cancer Trials Group
AstraZeneca; Cancer Research Institute, New York City; BioAtla, Inc.

Recruiting

Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer (IPROC)

Ovarian Cancer

United States, Canada
Dr. Nina Bhardwaj
Cancer Research Institute, New York City

Completed

Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine

Melanoma

United States
Ludwig Institute for Cancer Research
Cancer Research Institute, New York City; MedImmune LLC; Multiple Myeloma Research...

Terminated

Phase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell Transplant

Multiple Myeloma

United States
New York Glaucoma Research Institute

Unknown

A Study to Assess the Effect of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Uncontrolled Advanced Glaucoma With Prior Failed Trabeculectomy or Tube Shunt

Advanced Glaucoma

United States
New York Glaucoma Research Institute

Unknown

A Study to Assess the Effect of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Chronic Angle-closure Glaucoma (ROCK - CACG)

Chronic Angle-closure Glaucoma

United States
New York Glaucoma Research Institute

Unknown

A Compassionate Case Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Glaucoma Patients With Uncontrolled Intraocular Pressure to Avoid Surgical Intervention

Glaucoma

United States
Cancer Insight, LLC
Bristol-Myers Squibb; Cancer Research Institute, New York City; Akamis Bio

Active, not recruiting

Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma (REVOLUTION)

Metastatic Pancreatic Adenocarcinoma

United States
New York City Department of Health and Mental Hygiene
Public Health Solutions; The New York Academy of Medicine; New York City Health... and other collaborators

Active, not recruiting

ActionHealthNYC Research Study

Health Services Accessibility

United States
Revimmune
M.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Cancer Research... and other collaborators

Terminated

InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O ) (ILIAD-7-US-O)

COVID-19 | Lymphocytopenia

United States
Memorial Sloan Kettering Cancer Center
New York University; The City College of New York; New York State Department...

Completed

DRIIVE (Data and Research on Interventions to Improve the Vehicular Environment)

Vehicular Environment

United States
Ludwig Institute for Cancer Research
Cancer Research Institute, New York City; MedImmune LLC; Cure Brain Cancer Foundation...

Completed

Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma

Glioblastoma

United States, Australia
Ludwig Institute for Cancer Research
Xcovery Holding Company, LLC; Cancer Research Institute, New York City; MedImmune...

Completed

Phase 1/2 Study of Ensartinib and Durvalumab, in ALK-rearranged Non-small Cell Lung Cancer

Carcinoma | NSCLC | Non-small Cell Lung Cancer

United States
Memorial Sloan Kettering Cancer Center
City University of New York

Active, not recruiting

Adaptation of Skills Training Manuals for Patients Receiving Hematopoietic Stem Cell Transplantation and Their Caregivers

Post Hematopoietic Stem Cell Transplantation

United States
City University of New York
Maimonides Medical Center

Recruiting

Use of Ritual Epost Postnatal Multivitamins During the Postpartum Period

Nutrition, Healthy | Lactation Disorder - Postpartum Condition or Complication

United States
New York State Psychiatric Institute
City University of New York, School of Public Health

Withdrawn

Treatment of Depersonalization Disorder With Repetitive Transcranial Magnetic Stimulation (rTMS)

Depersonalization Disorder

United States
Parker Institute for Cancer Immunotherapy
Bristol-Myers Squibb; Cancer Research Institute, New York City; Apexigen, Inc.

Completed

Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma

Metastatic Pancreatic Adenocarcinoma

United States
City University of New York
Maimonides Medical Center

Recruiting

Use of Ritual Prenatal Multivitamins for Pregnancy

Pregnancy Related | Nutrition, Healthy

United States
Craig L Slingluff, Jr
Cancer Research Institute, New York City; Ludwig Institute for Cancer Research

Terminated

Safety Study of a Helper Peptide Vaccine Plus Adjuvant Combinations for the Treatment of Melanoma (Mel63; CHAMP)

Melanoma

United States
Memorial Sloan Kettering Cancer Center
The City College of New York

Completed

Yoga Practice for Breast or Ovarian Cancer Patients

Breast Cancer | Ovarian Cancer

United States
Memorial Sloan Kettering Cancer Center
The City College of New York

Active, not recruiting

Assessment of Sensory Gating, Attention, and Executive Control in Breast Cancer

Breast Cancer

United States
New York State Psychiatric Institute
Duke University; Queens College, The City University of New York

Active, not recruiting

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment (CogTraining)

Cognitive Impairment | Mild Cognitive Impairment | Cognitive Decline | Memory Disorders | Memory Impairment | Cognitive Disorder

United States
Canadian Cancer Trials Group
Bristol-Myers Squibb; Cancer Research Institute, New York City; Personal Genome...

Terminated

Nivolumab Ipilimumab in Patients With hyperMutated Cancers Detected in Blood (NIMBLe) (NIMBLe)

Advanced Solid Tumors

United States, Canada
Queens College, The City University of New York
National Cancer Institute (NCI)

Unknown

Eating Away From Home and Mortality

Mortality
Canadian Cancer Trials Group
Cancer Research Institute, New York City; Personal Genome Diagnostics (PGDx); Mark Foundation for Cancer Research

Recruiting

Study of CTDNA Response Adaptive Immuno-Chemotherapy in NSCLC

Non-Small Cell Lung Cancer

Canada, United States
Nina Bhardwaj
Cancer Research Institute, New York City

Completed

Randomized, Double Blind, Placebo-controlled Topical Resiquimod Adjuvant for NY-ESO-1 Protein Vaccination

Tumors

United States
New York City Department of Health and Mental Hygiene
NYU Langone Health; Robert Wood Johnson Foundation; Riverdale Family Practice... and other collaborators

Completed

Evaluation of Integrating Self Blood Pressure Monitoring Into Urban Primary Care Practices (ESBPM)

Hypertension | Cardiovascular Disease

United States
City University of New York
National Institute of Mental Health (NIMH); New York City Department of Health...

Active, not recruiting

Testing a Novel Data-to-Suppression (D2S) Intervention Strategy in the Ryan White HIV/AIDS Program (D2S)

Hiv

United States
Memorial Sloan Kettering Cancer Center
The City College of New York; New York City Health and Hospitals Corporation; New York Presbyterian Queens and other collaborators

Active, not recruiting

Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
Baruch College City University of New York

Active, not recruiting

A Study of Attention and Memory Processes in Breast Cancer Survivors

Breast Cancer Survivors

United States
New York Stem Cell Foundation Research Institute

Recruiting

NYSCF Scientific Discovery Biobank

PTSD | Multiple Sclerosis | Cervical Cancer | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes | Macular Degeneration | Diabetes Mellitus, Type 1 | Parkinson Disease | Amyotrophic Lateral Sclerosis | Dementia | Ovarian Cancer | Alzheimer Disease | ALS | Vulvar Cancer | Post Traumatic Stress Disorder | Lewy Body Disease and other conditions

United States
New York University Cancer Institute
National Cancer Institute (NCI)

Completed

Thalidomide in Treating Patients With Gynecologic Sarcomas

Sarcoma | Endometrial Cancer

United States
New York Stem Cell Foundation Research Institute
Laser and Skin Surgery Center of New York

Active, not recruiting

Biological Sample Collection for Research and Biobanking

Macular Degeneration | Cancer | Diabetes Mellitus, Type 1 | Parkinson Disease | Alzheimer Disease | ALS | Huntington Disease

United States
Ludwig Institute for Cancer Research
Roswell Park Cancer Institute; New York University Cancer Institute

Completed

Vaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

United States
New York University
National Cancer Institute (NCI)

Completed

Caregivers' Strengths-Skills: Managing Older Cancer Patients' Symptoms (FamCare)

Cancer
City University of New York
Bronx Veterans Medical Research Foundation, Inc

Terminated

Activity-Dependent Transspinal Stimulation in SCI

Spinal Cord Injuries | Tetraplegia/Tetraparesis | Paraplegia, Spinal | Paraplegia, Spastic

United States
Queens College, The City University of New York
National Institute of Mental Health (NIMH); New York State Psychiatric Institute

Withdrawn

Enhancing Processing Speed and Executive Functioning in Depressed Older Adults With Computerized Cognitive Training

Depression | Depression in Old Age

United States
Memorial Sloan Kettering Cancer Center
Northwestern University; The City College of New York

Completed

Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)

Anal High-Grade Squamous Intraepithelial Lesions

United States
Memorial Sloan Kettering Cancer Center
Hunter College of City University of New York

Completed

Study of Cognitive Behavioral Therapy for Insomnia (CBT-I) and Acupuncture for Insomnia and Related Distress Among Cancer Caregivers

Insomnia | Related Distress Among Cancer Caregivers

United States
New York State Psychiatric Institute
Stanley Medical Research Institute

Completed

Kuvan in People With Schizophrenia and Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
Parker Institute for Cancer Immunotherapy
Bristol-Myers Squibb; Cancer Research Institute, New York City; Celldex Therapeutics and other collaborators

Completed

Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations (PORTER)

Metastatic Castration-resistant Prostate Cancer

United States
Nina Bhardwaj
Cancer Research Institute, New York City; Ludwig Institute for Cancer Research and other collaborators

Completed

Safety Study of Adjuvant Vaccine to Treat Melanoma Patients

Melanoma

United States
New York State Psychiatric Institute
Stanley Medical Research Institute

Completed

TDCS for Auditory Hallucinations in Schizophrenia

Schizophrenia

United States
New York State Psychiatric Institute
Stanley Medical Research Institute

Completed

Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
The City College of New York
National Cancer Institute (NCI); Virginia Tech Carilion School of Medicine...

Completed

Enhancing Relapse Prevention for Smoking Cessation With Repetitive Transcranial Magnetic Stimulation (rTMS)

Smoking Cessation

United States

Clinical Trials Sponsored by Cancer Research Institute, New York City

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations